Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue
Aliment Pharmacol Ther
.
2022 Sep;56(5):903-904.
doi: 10.1111/apt.17136.
Authors
Lorenzo Bertani
1
2
,
Domenico Tricò
3
4
Affiliations
1
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
2
Department of General Surgery, Tuscany North-West ASL, Pontedera Hospital, Pontedera, Italy.
3
Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
4
Sant'Anna School of Advanced Studies, Institute of Life Sciences, Pisa, Italy.
PMID:
35934852
DOI:
10.1111/apt.17136
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Humans
Inflammatory Bowel Diseases* / drug therapy
Thyroxine / therapeutic use
Triiodothyronine*
Substances
Biomarkers
Triiodothyronine
Thyroxine